Frontlight ResearchEarly access
Retinitis pigmentosa trials in Italy
2 of 4 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 3Not yet taking people in ItalyA Phase 1/2/3 Study of ATSN-201 Gene Therapy in Subjects with RS1-Associated X linked Retinoschisis
- Where
- Milan, Naples
- People
- 36 worldwide
- Run by
- Atsena Therapeutics Inc.
See details and how to joinNCT05878860 · EU 2026-525886-38-00 - Phase 1/2Taking peopleStudy of Subretinally Injected AAVB-081 in Patients With Usher Syndrome Type IB (USH1B) Retinitis Pigmentosa
- Where
- Naples
- Age
- 18 years to 50 years
- People
- 15 worldwide
- Run by
- AAVantgarde Bio Srl
See details and how to joinNCT06591793